These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30776883)
1. Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea. Kim HS; Nam CM; Jang SY; Choi SK; Han M; Kim S; Moneta MV; Lee SY; Cho JM; Novick D; Rha SY Cancer Res Treat; 2019 Oct; 51(4):1380-1391. PubMed ID: 30776883 [TBL] [Abstract][Full Text] [Related]
2. Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database. Kang S; Kim HS; Choi ES; Han I Cancer Res Treat; 2015 Oct; 47(4):575-82. PubMed ID: 25687875 [TBL] [Abstract][Full Text] [Related]
3. Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study. Oh CR; Hong JY; Kim JH; Lee JS; Kim HS; Kim TW; Ahn JH; Kim JE Target Oncol; 2020 Aug; 15(4):485-493. PubMed ID: 32607656 [TBL] [Abstract][Full Text] [Related]
4. Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan. Nakamura T; Asanuma K; Hagi T; Sudo A Drug Des Devel Ther; 2020; 14():4215-4220. PubMed ID: 33116409 [TBL] [Abstract][Full Text] [Related]
5. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395 [TBL] [Abstract][Full Text] [Related]
6. Extremity soft tissue sarcoma with multiple primary malignancies--Characteristics and outcome. Lopez-Oliva CL; Yun JY; Kim HS; Han I Eur J Surg Oncol; 2016 Apr; 42(4):567-73. PubMed ID: 26873637 [TBL] [Abstract][Full Text] [Related]
7. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival. Garbay D; Maki RG; Blay JY; Isambert N; Piperno Neumann S; Blay C; Zanardi E; Boudou-Rouquette P; Bozec L; Duffaud F; Bertucci F; Italiano A Ann Oncol; 2013 Jul; 24(7):1924-1930. PubMed ID: 23493135 [TBL] [Abstract][Full Text] [Related]
9. [An analysis of incidence trends and characteristics of soft tissue sarcoma in Beijing, 1999-2013]. Yang L; Fang ZW; Fan ZF; Wang N; Yuan YN; Li HC; Liu S Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):471-476. PubMed ID: 28635239 [No Abstract] [Full Text] [Related]
10. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases. Bessen T; Caughey GE; Shakib S; Potter JA; Reid J; Farshid G; Roder D; Neuhaus SJ Cancer Epidemiol; 2019 Dec; 63():101590. PubMed ID: 31520939 [TBL] [Abstract][Full Text] [Related]
11. Update on systemic therapy for advanced soft-tissue sarcoma. Smrke A; Wang Y; Simmons C Curr Oncol; 2020 Feb; 27(Suppl 1):25-33. PubMed ID: 32174755 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials. Younger E; Litière S; Le Cesne A; Mir O; Gelderblom H; Italiano A; Marreaud S; Jones RL; Gronchi A; van der Graaf WTA Oncologist; 2018 Oct; 23(10):1250-1259. PubMed ID: 29650688 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in soft tissue sarcoma. Maretty-Nielsen K Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967 [TBL] [Abstract][Full Text] [Related]
14. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study. Zhang Y; Wu Z; Chang J; Jiang W; Wang Y; Wang H; Li J; Li C; Li X Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):689-698. PubMed ID: 33115276 [No Abstract] [Full Text] [Related]
15. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan. Hung GY; Yen CC; Horng JL; Liu CY; Chen WM; Chen TH; Liu CL Medicine (Baltimore); 2015 Oct; 94(41):e1696. PubMed ID: 26469906 [TBL] [Abstract][Full Text] [Related]
16. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015 [TBL] [Abstract][Full Text] [Related]
17. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Kollár A; Rothermundt C; Klenke F; Bode B; Baumhoer D; Arndt V; Feller A; Cancer Epidemiol; 2019 Dec; 63():101596. PubMed ID: 31520938 [TBL] [Abstract][Full Text] [Related]
18. Challenges of Using ICD-9-CM and ICD-10-CM Codes for Soft-Tissue Sarcoma in Databases for Health Services Research. Hess LM; Zhu YE; Sugihara T; Fang Y; Collins N; Nicol S Perspect Health Inf Manag; 2019; 16(Spring):1a. PubMed ID: 31019431 [TBL] [Abstract][Full Text] [Related]
19. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG. Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I; Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349 [TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of treatment patterns among recurrent/metastatic soft tissue sarcoma patients who consulted medical oncologists in Japan. Nakano K; Ae K; Matsumoto S; Takahashi S J Orthop Sci; 2019 Nov; 24(6):1081-1087. PubMed ID: 31447093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]